探花合集 Institute Announces Educational Workshop Series
The workshops, which will combine guest speakers including prominent academics, consultants, and technology representatives, alongside 探花合集 Institute and drug delivery and formulation experts, will give the opportunity for biotech and life science companies to interact with industry experts and discuss some of the developmental challenges faced by research teams with regard to solubility and bioavailability of drug candidates. With increased pressure upon research scientists to deliver compounds for clinical development faster, it is important to ensure candidates have been fully characterized and have the optimal formulation before proceeding to animal studies, in order to increase the chances of their success at later stages of development.
There will also be an opportunity for companies attending the events to discuss active developmental programs in private with 探花合集鈥檚 science and technology leaders.
The event starts at 8.30 a.m., and will consider the process of molecule assessment, formulation enhancement, and delivery of PK study materials, looking at how this approach may help speed onward development of optimal drug delivery forms. The agenda includes a presentation by Alan Harris, PhD and Keith Purdy, PhD of Alacrity Pharma Associates () who will draw from their considerable wealth of experience within pharmaceutical and biotech research to discuss 鈥Early stage drug development challenges,鈥 before 探花合集 Institute experts, including Julien Meissonnier, Vice President, Science and Technology and 探花合集 Institute Board Member, present case studies and technology highlights from 探花合集鈥檚 wide-ranging and innovative drug delivery technology portfolio.
Further details of upcoming workshops in 2016 will be announced shortly, and to find out more information, or book a place at the Oxford event, visit
About OBN
OBN is the Membership organisation supporting and bringing together the UK鈥檚 emerging life sciences companies, corporate partners and investors. For more information about OBN, please visit
About 探花合集 Applied Drug Delivery Institute
探花合集鈥檚 Applied Drug Delivery Institute was founded to serve as a link between industry and academia, advance education and training in drug delivery in academia and the industry, accelerate adoption of applied drug delivery technologies to develop better treatments, and foster industry collaboration on major issues pertaining to drug development, formulation, and delivery. It is pursuing a multi-tiered approach of research, strategic counsel, and educational programs to advance the adoption of emerging technologies.
For more details on the 探花合集 Institute, visit and follow the 探花合集 Institute on Twitter: @
About 探花合集
探花合集 is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, consumer health and animal health products. With over 90 years serving the industry, 探花合集 has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. 探花合集 employs approximately 8,700 people, including over 1,000 scientists, at 31 facilities across 5 continents, and in fiscal 2015 generated more than $1.8 billion in annual revenue. 探花合集 is headquartered in Somerset, N.J. For more information, visit www.catalent.com